{"url_path":"/sec/okyo/10-k/2026/item-16b","section_key":"item-16b","section_title":"Item 16B CODE OF ETHICS**","topic":"sec","document":{"doc_type":"20-F","doc_date":"2026-07-20","source_url":"https://www.sec.gov/Archives/edgar/data/1849296/0001493152-26-033847-index.html","accession_number":"0001493152-26-033847","cik":"0001849296","ticker":"OKYO","issuer_name":"OKYO Pharma Ltd","edgar_url":"https://www.sec.gov/Archives/edgar/data/1849296/0001493152-26-033847-index.html","primary_entity_key":"0001849296","primary_entity_name":"OKYO Pharma Ltd"},"word_count":150,"has_tables":true,"body_markdown":"**ITEM\n16B: CODE OF ETHICS**\n\n \n\nOur\nCode of Business Conduct and Ethics is applicable to all of our employees, officers and directors and is available on our website at\nhttps://www.okyopharma.com. Our Code of Business Conduct and Ethics provides that our directors and officers are expected to avoid any\naction, position or interest that conflicts with the interests of our company or gives the appearance of a conflict. Our directors and\nofficers have an obligation under our Code of Business Conduct and Ethics to advance our company’s interests when the opportunity\nto do so arises. We expect that any amendment to this code, or any waivers of its requirements, will be disclosed on our website. Information\ncontained on, or that can be accessed through, our website is not incorporated by reference into this Annual Report, and you should not\nconsider information on our website to be part of this Annual Report."}